---
title: "Coral Laboratories Ltd (524506) — Share Price, Financials & Analysis"
symbol: "524506"
company: "Coral Laboratories Ltd"
canonical: "https://tapetide.com/stocks/524506"
isin: "INE683E01017"
nse_symbol: "CORALLABORATORIESLTD"
bse_code: "524506"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 209.22
generated_at: "2026-09-13T18:27:42.901Z"
---

# Coral Laboratories Ltd (524506)

Canonical page: https://tapetide.com/stocks/524506

## Company

- **NSE Symbol:** CORALLABORATORIESLTD
- **BSE Code:** 524506
- **ISIN:** INE683E01017
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** corallab.com

## About

Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:45:29.573279Z.

- **Market Cap:** ₹209.22 Cr
- **Classification:** Microcap
- **P/E (reported):** 10.4
- **EPS (TTM):** ₹53.77
- **EPS (reported):** ₹44.58
- **Book Value:** ₹585.74
- **Price to Book:** 0.96
- **Dividend Yield:** 0.36%
- **ROE:** 7.83%
- **ROCE:** 10.91%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹95.8 Cr
- **Net Income:** ₹16.4 Cr
- **EBITDA:** ₹25.1 Cr
- **52-Week High:** ₹679
- **52-Week Low:** ₹360
- **RSI (14):** 38.42

## Tapetide Score

- **Score:** 62 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Rising
- **Percentile:** 92.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 85.35 | 9% |
| growth | 30.3 | 9% |
| momentum | 90.11 | 12% |
| ownership | 50 | 24% |
| quality | 48.97 | 22% |
| valuation | 71.79 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 1.00 times its book value

### Weaknesses

- The company has delivered a poor sales growth of -2.31% over past five years.
- Company has a low return on equity of 10.1% over last 3 years.
- Earnings include an other income of Rs.10.3 Cr.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 77.66% | -109.63% | -231.18% |
| ebitda margin growth | -13.64% | -7.97% | 3.47% | 61.79% |
| net income growth | 3.85% | -32.23% | 36% | 3% |
| revenue growth | 9.28% | -22.8% | 3% | -2% |
| roce | — | -31.51% | -4.88% | 10.18% |
| roe | — | -34.8% | 9.58% | 35% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 23.15 | 18.08 | 28.89 | 31.66 | 32.23 | 22.99 | 28.13 | 18.82 | 19.03 | 21.56 | 26.48 | 29.62 |
| Expenses | 17 | 15.98 | 22.64 | 20.92 | 25.72 | 16.67 | 25.44 | 16.64 | 14.09 | 19.67 | 20.28 | 24.13 |
| Operating Profit | 6.15 | 2.1 | 6.25 | 10.74 | 6.51 | 6.32 | 2.69 | 2.18 | 4.94 | 1.89 | 6.2 | 5.49 |
| OPM % | 26.57 | 11.62 | 21.63 | 33.92 | 20.2 | 27.49 | 9.56 | 11.58 | 25.96 | 8.77 | 23.41 | 18.53 |
| Other Income | 1.81 | 1.37 | 2 | 1.56 | 2.54 | 2.52 | 1.71 | 2.05 | 3.03 | 2.49 | 2.64 | 2.15 |
| Interest | 0 | 0 | 0 | 0.03 | 0.01 | 0.02 | 0.04 | 0.06 | 0.1 | 0 | 0.01 | 0.03 |
| Depreciation | 0.44 | 0.49 | 0.5 | 0.49 | 0.51 | 0.5 | 0.51 | 0.45 | 0.45 | 0.69 | 0.54 | 0.66 |
| Profit before tax | 7.52 | 2.98 | 7.75 | 11.78 | 8.53 | 8.32 | 3.85 | 3.72 | 7.42 | 3.69 | 8.29 | 6.95 |
| Tax % | 20.21 | 27.52 | 25.16 | 25.21 | 25.21 | 26.08 | 26.49 | 31.18 | 21.56 | 24.93 | 36.91 | 22.45 |
| Net Profit | 6 | 2.16 | 5.79 | 8.8 | 6.38 | 6.14 | 2.83 | 2.56 | 5.82 | 2.78 | 5.22 | 5.39 |
| EPS in Rs | 16.79 | 6.05 | 16.21 | 24.63 | 17.86 | 17.19 | 7.92 | 7.17 | 16.29 | 7.78 | 14.61 | 15.09 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 92 | 91 | 71 | 97 | 76 | 78 | 84 | 115 | 86 | 97 |
| Expenses | 77 | 79 | 65 | 81 | 67 | 74 | 67 | 89 | 71 | 78 |
| Operating Profit | 15 | 12 | 5 | 16 | 8 | 4 | 16 | 26 | 15 | 19 |
| OPM % | 17 | 14 | 8 | 16 | 11 | 4.9 | 19 | 23 | 18 | 19 |
| Other Income | 4 | 5 | 6 | 4 | 6 | 7 | 6 | 8 | 10 | 10 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 18 | 16 | 9 | 18 | 12 | 8 | 21 | 32 | 23 | 26 |
| Tax % | 31 | 34 | 22 | 23 | 24 | 22 | 24 | 26 | 29 | — |
| Net Profit | 12 | 10 | 7 | 14 | 9 | 6 | 16 | 24 | 16 | 19 |
| EPS in Rs | 34.85 | 28.61 | 19.96 | 37.93 | 25.33 | 18.05 | 44.2 | 67.63 | 45.85 | 53.77 |
| Dividend Payout % | 6 | 7 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 106 | 113 | 110 | 112 | 133 | 152 | 151 | 174 | 198 | 206 |
| Borrowings | 2 | 2 | 1 | 6 | 6 | 6 | 0 | 0 | 4 | 4 |
| Other Liabilities | 20 | 22 | 21 | 23 | 25 | 28 | 20 | 28 | 25 | 27 |
| Total Liabilities | 131 | 140 | 136 | 144 | 168 | 190 | 174 | 206 | 229 | 241 |
| Fixed Assets | 18 | 22 | 23 | 23 | 21 | 24 | 25 | 24 | 23 | 44 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 |
| Investments | 39 | 45 | 28 | 25 | 33 | 46 | 41 | 50 | 52 | 46 |
| Other Assets | 74 | 73 | 84 | 97 | 112 | 118 | 108 | 132 | 152 | 150 |
| Total Assets | 131 | 140 | 136 | 144 | 168 | 190 | 174 | 206 | 229 | 241 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 11 | 13 | -1 | -4 | 1 | 6 | 13 | -5 | -1 | 16 |
| Cash from Investing Activity | -10 | -13 | 3 | -2 | 0 | -6 | -3 | 1 | 0 | -18 |
| Cash from Financing Activity | 0 | -3 | -1 | 4 | 0 | 0 | -6 | 0 | 3 | 0 |
| Net Cash Flow | 1 | -2 | 1 | -2 | 1 | 0 | 4 | -4 | 1 | -2 |
| Free Cash Flow | 9 | 9 | -4 | -5 | 0 | 1 | 11 | -6 | -4 | -5 |
| CFO/OP | 85 | 124 | 31 | -59 | 28 | 127 | 383 | -4 | 23 | 150 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 117 | 125 | 122 | 178 | 148 | 184 | 109 | 123 | 107 | 125 |
| Inventory Days | 155 | 120 | 116 | 176 | 158 | 169 | 100 | 149 | 68 | 211 |
| Days Payable | 75 | 87 | 91 | 129 | 108 | 81 | 34 | 130 | 46 | 103 |
| Cash Conversion Cycle | 197 | 157 | 146 | 225 | 198 | 272 | 176 | 142 | 129 | 233 |
| Working Capital Days | 164 | 161 | 171 | 241 | 178 | 222 | 221 | 183 | 140 | 203 |
| ROCE % | 28 | 16 | 13 | 8 | 13 | 7 | 5 | 13 | 17 | 11 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| FIIs | 0.14% | 0.14% | 0.14% | 0.23% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 20.9% | 20.87% | 20.82% | 20.33% | 21.18% | 20.99% | 20.91% | 20.76% | 20.8% | 20.52% | 19.93% | 19.93% |
| Others | 7.44% | 7.48% | 7.52% | 7.93% | 7.31% | 7.5% | 7.58% | 7.72% | 7.69% | 7.97% | 8.56% | 8.56% |
| No. of Shareholders | 3981 | 4005 | 4098 | 3831 | 3949 | 4054 | 4105 | 4213 | 4286 | 4208 | 4084 | 3873 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 7 / 6 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 583.08 | Buy |
| EMA (10) | 585.69 | Sell |
| SMA (20) | 612.75 | Sell |
| EMA (20) | 594.06 | Sell |
| SMA (50) | 594.65 | Sell |
| EMA (50) | 584.91 | Buy |
| SMA (100) | 543.12 | Buy |
| EMA (100) | 555.14 | Buy |
| SMA (200) | 492.53 | Buy |
| EMA (200) | 538.42 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.97 | Neutral |
| MACD (12,26,9) | -6.26 | Sell |
| Stochastic (14,3,3) | 15.79 | Buy |
| ADX (14) | 18.33 | Neutral |
| Williams %R (14) | -74.69 | Neutral |
| ATR (14) | 31.72 | High Volatility |
| ROC (12) | -9.3 | Sell |
| Stoch RSI (14) | 36.26 | Neutral |
| UO (7,14,28) | 30.77 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08779ebe-e649-412b-9c1c-d6476f1802cf.pdf) |
| 2026-09-04 | [Notice Of 44Th AGM Scheduled To Be Held On September 29 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a34f29c-61d0-4341-ade3-194326780fc8.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2eb0488e-3d34-4a11-94d0-29e22c77e3fc.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75763af5-7448-48cb-80e5-99838f15f318.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2822189c-8c80-4ca8-951f-fe22eff16e92.pdf) |
| 2026-08-14 | [Notice Of Book Closure And Record Date](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4c00f12-da09-47d8-b1a1-3d2e25210263.pdf) |
| 2026-08-14 | [Intimation For Holding 44Th AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=900fa94e-6044-4c0c-bd66-9f3cd259c8ec.pdf) |
| 2026-08-14 | [Notice Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54c9f9a8-9615-4c3a-8520-d9fd9904dc91.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=879ac20c-0ebd-407f-8e54-bd352d919ddf.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Intimation Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aa03f88-e54a-4759-90c4-4c7b14bf72e9.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Financial Results For The Quarter Ended On June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0efd49df-d7ae-4511-9164-9724b73ef57c.pdf) |
| 2026-05-30 | [Results For The Financial Year Ended On March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d804e04-8ce4-48a8-918e-1489af0d6dfd.pdf) |
| 2026-02-13 | [Financial Result For The Quarter Ended December 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80371597-02a7-4c3a-ad7b-3acc1f32c913.pdf) |
| 2025-11-14 | [Results - Financial Results For Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e83b423-4156-4de3-b80c-f130f1116880.pdf) |
| 2025-08-13 | [Outcome Of Board Meeting Held On August 13 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87d4abff-767e-4e3e-a439-26f66439ce59.pdf) |
| 2025-05-30 | [Finacial Result For The Financial Year Ending March 31 2025 Outcome Of Board Meeting Held On May 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47368ce6-2f7d-4f90-bd54-9777ec6a481e.pdf) |
| 2025-02-13 | [To Consider And Adopt The Unaudited Standalone Financial Results For The Quarter And Nine Months Ended December 31 2024 With The Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3430161-8c8b-42ba-b06c-d753b190fbc8.pdf) |
| 2024-11-26 | [Submission Of Limited Review Report Missed Inadvertently In Financial Result Submitted On 14Th November, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=795d8036-7725-4b0b-8e48-d286ccd6c7e0.pdf) |
| 2024-11-14 | [Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2024, As Per Regulation 33 Under SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8801604f-7be6-4bc4-8569-982f70a5a6c3.pdf) |
| 2024-08-14 | [Submission Of Standalone Unaudited Financial Results Of Coral Laboratories Limited For The Quarter Ended June 30, 2023 Along With Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7276fa62-8e23-44d3-b417-33b08c6fcb26.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 May - Postal ballot passed reappointment of Mr. Malay Doshi as Independent Director on May 6, 2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 7 May - Postal ballot passed reappointment of Mr. Malay Doshi as Independent Director on May 6, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b983e689-d30d-4a02-83b4-11b8272f2211.pdf) |
| 7 May - Postal ballot e-voting on May 6, 2026 passed reappointment of Independent Director Malay Doshi. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 7 May - Postal ballot e-voting on May 6, 2026 passed reappointment of Independent Director Malay Doshi.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a771465a-bcfe-4ada-9879-b80ba22a58dd.pdf) |
| 6 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, furnished by M/s. MUF Intime India Private Limited (formerly known as 'Link Intime India … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, furnished by M/s. MUF Intime India Private Limited (formerly known as 'Link Intime India …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aba7715d-17dd-49bf-b659-5add6d9cbc63.pdf) |
| 5 Feb - Board meeting Feb 13, 2026 to approve unaudited Q3 and 9-month results ended Dec 31, 2025; trading window closed. | [Board Meeting Intimation for Intimation Of Board Meeting To Consider Financial Result For The Quarter And Nine Months Ended On December 31, 2025 5 Feb - Board meeting Feb 13, 2026 to approve unaudited Q3 and 9-month results ended Dec 31, 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/54677c90-388f-47ef-906b-24a7d2e415e2.pdf) |
| 30 Dec 2025 - Coral Laboratories: Company Secretary Dhwani Desai resigns, effective January 31, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 30 Dec 2025 - Coral Laboratories: Company Secretary Dhwani Desai resigns, effective January 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a26c26d8-a749-4b02-90ce-b1ef7d669732.pdf) |
| 30 Apr - Coral Laboratories says it is not a large corporate; outstanding long-term borrowing was nil on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Coral Laboratories says it is not a large corporate; outstanding long-term borrowing was nil on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/83daa3bd-a75a-47a3-ab68-0ca36bd3efb2.pdf) |
| 30 Apr - Coral Laboratories says it is not a large corporate; outstanding long-term borrowing was nil on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Coral Laboratories says it is not a large corporate; outstanding long-term borrowing was nil on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/83daa3bd-a75a-47a3-ab68-0ca36bd3efb2.pdf) |
| 27 Apr - Received MSEFC Surat notice under MSMED Act over ₹2,04,853.20 claim; company will contest. | [Regarding Receipt Of Notice Under Section 18 Of MSMED Act, 2006. 27 Apr - Received MSEFC Surat notice under MSMED Act over ₹2,04,853.20 claim; company will contest.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b3bccc2-2550-41a7-b7a0-33c7a54549c0.pdf) |
| 23 Mar - Dehradun ointment unit expanded to 360,000 kgs; commercial operations commenced March 23, 2026. | [Completion Of Capacity Expansion At Dehradun Plant 23 Mar - Dehradun ointment unit expanded to 360,000 kgs; commercial operations commenced March 23, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/97a89e8a-fe5e-4517-af5b-c1f98f2f1b7e.pdf) |
| 23 Apr - Coral Laboratories appointed Diwakar U. Menon as Company Secretary and Compliance Officer from April 30, 2026. | [Board Meeting Outcome for Appointment Of Mr. Diwakar Unnikrishna Menon (ACS: 8791) As Company Secretary And Compliance Officer Of The Company 23 Apr - Coral Laboratories appointed Diwakar U. Menon as Company Secretary and Compliance Officer from April 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d00831d-38c5-44bd-8944-d2f9fd116e70.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_DHANUS_2011_2012_14092012102601.zip) |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_DHANUS_2010_2011_18072011150000.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ade08d82-9818-460a-a1bd-16cb2ad44efc.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ad966ba5-1305-44d2-9d27-e06c8fbe4173.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbe203dd-9742-43cf-9b79-b9b2dc1d48ec.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524506/76030524506.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524506/70399524506.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524506/5245060320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524506/5245060319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524506/5245060318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:27:42.901Z.